What Is On-Demand Foundation Manufacturing and Why Hasn’t It Happened Yet?
On-demand foundation manufacturing, which mixes pigment and base at point of sale rather than in centralized factories, has remained elusive despite decades of industry discussion. Technical barriers around precision dispensing, regulatory uncertainty under FDA's Modernization of Cosmetics Regulation Act, and lack of supporting infrastructure have prevented widespread adoption. While previous attempts proved technical feasibility, they failed on ecosystem design and cost structure. New infrastructure platforms are emerging that solve these barriers through micro-dosing precision, authenticated refill systems, and clear regulatory positioning that enables brands to offer personalization without building capabilities internally.
Key Takeaways
Traditional cosmetics manufacturing requires minimum order quantities of 500-20,000 units, creating path dependency that prevents true on-demand production at point of sale
Technical barriers including precision dispensing at small scale, contamination control, and cleaning protocols have prevented widespread adoption of on-demand foundation manufacturing
FDA's MoCRA regulation assigns "Responsible Person" liability to manufacturers, packers, or distributors appearing on labels, creating compliance complexity for distributed manufacturing models that infrastructure platforms must clarify
Previous personalized beauty device attempts proved technical feasibility but failed due to ecosystem design flaws, high consumer costs, and lack of authenticated supply chains
Infrastructure platforms that solve technical, regulatory, and economic barriers enable beauty brands to adopt on-demand manufacturing without building internal capabilities, positioning technology as enabling rather than competitive
The Batch Manufacturing Lock-In: How Cosmetics Production Evolved for Scale
Cosmetics manufacturing evolved for mass production efficiency. Contract manufacturers operate facilities optimized for large minimum order quantities, creating path dependency that constrains innovation. According to Fortune International, cosmetic MOQs typically range from 500 to 20,000 units depending on product complexity, with Bioatoms noting that traditional manufacturers often require 5,000 to 10,000 units per SKU.
This scale requirement shapes product development. Brands design formulations for existing manufacturing capabilities because alternative infrastructure does not exist. The "personalization" offered by many brands operates within these batch constraints; consumers select from pre-manufactured options, or small batches created in centralized facilities and shipped to retail. True on-demand manufacturing, mixing at point of sale or point of use, requires fundamentally different production physics that challenge these entrenched economics.
The Technical Barriers to Point-of-Sale Manufacturing
Four technical challenges have prevented on-demand cosmetics from achieving commercial viability. First, precision at small scale presents engineering hurdles. As Next Pangaea explains, industrial mixing achieves homogeneity through turbulence in large volumes; manufacturing tanks typically require at least two-thirds capacity (around 200kg for a 300kg tank) to function properly. At retail dispense volumes, achieving consistent dispersion requires mechanical precision beyond standard pump systems.
Second, contamination control becomes critical with frequent, small-scale operations. Third, dispensing accuracy across varying viscosities challenges traditional valve systems. Fourth, cleaning and reset between dispenses requires eliminating residual product without disassembly; standard valve systems create dead zones where product accumulates, compromising the next formulation.
Micro-dosing technology offers solutions. Blank Beauty's patented micro-dosing robotics demonstrate precision automation capable of handling complex color chemistry, while Aptar's micro-dosage cosmetic pumps achieve outputs as low as 70 microliters for precise treatment application. Hale Cosmeceuticals notes that microfluidic techniques enable precise control over fluid movement at microscale, allowing reliable reproduction of formulations that meet stringent quality standards.
The Regulatory Complexity: Who Is the Manufacturer?
FDA's Modernization of Cosmetics Regulation Act (MoCRA), enacted December 29, 2022, introduced significant compliance requirements that complicate on-demand manufacturing. According to the FDA, the "Responsible Person" is defined as "the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label of such cosmetic product."
Worldover clarifies that full legal compliance and liability remains with this Responsible Person, and unlike UK and EU regulations, MoCRA contains no provision for legally designating this role to a third party via mandate. Registrar Corp explains that Responsible Persons must maintain adverse event records for six years, submit serious adverse event reports within 15 business days, and ensure adequate safety substantiation for each product.
On-demand manufacturing complicates this designation. When infrastructure mixes components at retail, the lines between manufacturer, packer, and distributor blur. AFS Law notes that facility registrations must be renewed biennially and product listings updated annually, creating ongoing compliance obligations that distributed manufacturing models must address. This regulatory uncertainty has slowed investment despite clear consumer demand for personalization.
Previous Attempts and Infrastructure Lessons
Previous personalized beauty device launches demonstrated technical feasibility but failed to achieve scale due to ecosystem limitations. Attempts by major beauty conglomerates proved that precision dispensing works in controlled environments, but these efforts struggled with quality control risks on refills, single-brand limitations that prevented ecosystem growth, high consumer device costs that created adoption barriers, and lack of authenticated supply chains that ensured ingredient integrity.
The fundamental lesson: technology alone cannot overcome flawed market architecture. Successful on-demand manufacturing requires not just dispensing precision, but authenticated refill systems, multi-brand participation to amortize infrastructure costs, and regulatory frameworks that clarify liability in distributed manufacturing environments.
The Infrastructure Solution: Enabling Brands Without Competing
Emerging infrastructure platforms address each barrier through architectural innovation. Technical solutions combine micro-dosing precision with automated flush cycles that maintain hygiene between formulations. Regulatory positioning clarifies that infrastructure providers serve as manufacturing partners, not product manufacturers; brand partners retain Responsible Person status while leveraging distributed production capabilities.
Economic models distribute costs through B2B2C structures. Retailers or brands subsidize hardware; consumers pay per-use rather than purchasing expensive devices outright. OEM Cosmetic explains that small batch manufacturing focuses on flexibility and precision rather than volume, allowing brands to test new variants and maintain consistency without producing thousands of pieces at once.
Economic models distribute costs through B2B2C structures. Retailers or brands subsidize hardware; consumers pay per-use rather than purchasing expensive devices outright. OEM Cosmetic explains that small batch manufacturing focuses on flexibility and precision rather than volume, allowing brands to test new variants and maintain consistency without producing thousands of pieces at once.
Ecosystem design enables multi-brand participation through authenticated refill cartridges. This approach allows established beauty brands to offer on-demand personalization without building internal capabilities, positioning technology platforms as infrastructure partners similar to how Shopify enables e-commerce without competing with retailers.
For beauty brands evaluating innovation partnerships, the infrastructure model offers a pathway to personalization that avoids the capital expenditure and technical risk of proprietary development. By leveraging shared manufacturing platforms, brands can offer infinite shade customization without carrying infinite inventory, solving the SKU proliferation crisis while meeting consumer demand for individualization.